Financial Data and Key Metrics Changes - For Q4 2025, the company reported GAAP net income of $0.2 million and distributable earnings of $18.5 million, or $0.24 per common share [10] - For the full year 2025, GAAP net income was $45.5 million, or $0.57 per share, with distributable earnings of $76.8 million, or $0.97 per common share, achieving a coverage ratio of 1.01x on the annual dividend of $0.96 per share [10] - Book value per common share decreased to $11.07 from $11.25 quarter-over-quarter [10] Business Line Data and Key Metrics Changes - The company originated 20 loans with total commitments of $1.9 billion in 2025, with a weighted average credit spread of 2.82% [11] - The loan portfolio was 100% performing at year-end, with a weighted average risk rating unchanged at 3.0 [11] - The company upgraded 2 multifamily loans and downgraded 1 multifamily loan based on operational performance [12] Market Data and Key Metrics Changes - The company increased its exposure to multifamily and industrial collateral from 30% at the beginning of 2022 to over 72% of the current balance sheet [7] - The cost of funds declined by 18 basis points year-over-year, from 2.0% to 1.82% [13] - Total leverage increased to 3.02x from 2.64x quarter-over-quarter due to substantial loan origination volume [13] Company Strategy and Development Direction - The company aims to continue net asset growth through prudent investment and risk management, targeting a leverage ratio of 3.5-3.75x [8][25] - The focus remains on multifamily and industrial sectors, with plans to increase industrial exposure to 25%-30% [42] - The company is committed to maximizing shareholder value and exploring opportunities for growth, both organic and inorganic [36] Management's Comments on Operating Environment and Future Outlook - The broader economic backdrop is favorable for investment activity in the real estate sector, with increased capital allocation towards real estate credit [4] - The company anticipates a very active year for borrowers and lenders, driven by clarity around interest rates and favorable credit spreads [17] - Management expressed confidence in the ability to deliver strong performance in 2026, supported by a stable balance sheet and attractive investment opportunities [8] Other Important Information - The company ended the quarter with near-term liquidity of $143 million, including $72.6 million in cash available for investment [12] - The liability structure is 82% non-mark-to-market, an increase from 77% at the end of 2024 [13] Q&A Session Summary Question: Expectations for origination pace in Q1 2026 - Management indicated that the pipeline is robust, with significant activity across all property types and regions, suggesting a positive outlook for origination pace in 2026 [15] Question: Target leverage and REO assets - The target leverage is set at 3.5-3.75x, with plans to sell down REO assets throughout the year as market conditions improve [25][26] Question: Appropriate ROE target - Management believes that an ROE in excess of SOFR + 5% is achievable, reflecting the health of the back leverage market [30] Question: Closing the value gap in stock price - Management is focused on maximizing shareholder value and is actively seeking opportunities to close the valuation gap [35] Question: Industrial exposure growth - Industrial exposure has increased significantly, with a target level of 25%-30% anticipated as the company continues to assess market conditions [42]

Financial Data and Key Metrics Changes - For Q4 2025, the company reported GAAP net income of $0.2 million and distributable earnings of $18.5 million, or $0.24 per common share [11] - For the full year 2025, GAAP net income was $45.5 million, or $0.57 per share, with distributable earnings of $76.8 million, or $0.97 per common share, achieving a coverage ratio of 1.01x on the annual dividend of $0.96 per share [11] - Book value per common share decreased from $11.25 to $11.07 quarter-over-quarter [11] Business Line Data and Key Metrics Changes - In 2025, the company originated 20 loans totaling $1.9 billion, with a weighted average credit spread of 2.82% [12] - The loan portfolio was 100% performing at year-end, with a weighted average risk rating unchanged at 3.0 [12] - The company closed $927 million in new loans in Q4 2025, with 62% in multifamily and 38% in industrial collateral [5] Market Data and Key Metrics Changes - The company increased its exposure to multifamily and industrial collateral from 30% at the beginning of 2022 to over 72% by year-end 2025 [7] - The cost of funds declined by 18 basis points year-over-year, from 2.0% to 1.82% [14] - Total leverage increased to 3.02x from 2.64x quarter-over-quarter due to substantial loan origination volume [14] Company Strategy and Development Direction - The company aims to continue net asset growth through prudent investment and risk management, targeting a leverage ratio of 3.5-3.75x [9][27] - The focus remains on maintaining strong relationships with repeat borrowers and optimizing the capital structure [6][8] - The company plans to continue increasing its industrial exposure, targeting a range of 25%-30% in the future [43] Management's Comments on Operating Environment and Future Outlook - The broader economic backdrop is favorable for investment activity in real estate, with increased capital allocation towards real estate credit [4] - The company is optimistic about 2026, citing a robust pipeline and favorable market conditions for continued growth [17][19] - Management emphasized the importance of maintaining a stable balance sheet and leveraging TPG's real estate investment platform for future performance [9] Other Important Information - The company ended the quarter with near-term liquidity of $143 million, including $72.6 million in cash available for investment [13] - The liability structure is 82% non-mark-to-market, reflecting improvements from the issuance of two CRE CLOs totaling $2.2 billion [14] Q&A Session Summary Question: Expectations for origination pace in Q1 2026 - Management indicated that origination volumes in Q4 2025 were strong and expect a robust pipeline for 2026, with many borrowers actively seeking financing [17] Question: Loan spreads and market competition - Management noted that while loan spreads were tighter, the cost of funds moved in line, and competition for back leverage remains strong [20][21] Question: Target leverage and REO assets - The target leverage is set at 3.5-3.75x, with plans to sell down REO assets as the market improves [27][28] Question: Long-term ROE targets - Management stated that an ROE in excess of SOFR + 500 basis points is achievable, reflecting the health of the back leverage market [32] Question: Closing the value gap in stock price - Management is focused on maximizing shareholder value and is actively seeking opportunities for growth and scaling [36][37] Question: Industrial exposure and future targets - Management confirmed that industrial exposure has increased significantly and anticipates further growth, targeting 25%-30% in the future [43]

Financial Data and Key Metrics Changes - For Q4 2025, the company reported GAAP net income of $0.24 per share, while distributable earnings (DE) were -$2.07 per share, with DE prior to charge-offs at -$0.51 per share, reflecting a 20% increase from Q1 [3][19] - The company paid a dividend of -$0.47 per share for Q4, with DE prior to charge-offs covering the dividend for the second consecutive quarter [4][20] - Book value ended the year at $20.75 per share, which includes $0.47 per share of accumulated depreciation and amortization [21] Business Line Data and Key Metrics Changes - The loan portfolio is now 99% performing, with $575 million of impaired loans resolved during the quarter, reducing the impaired loan balance to just under $90 million [4][12] - The investment portfolio increased to $20 billion, up from $19.5 billion, with the loan portfolio at $18 billion and net lease assets now representing 5% of the portfolio [12][20] - In Q4, the company closed $1.5 billion of investments, including $1.4 billion of new loan originations, all secured by multifamily and industrial assets [10][11] Market Data and Key Metrics Changes - The real estate credit market is highly liquid, with CMBS issuance up 40% year-over-year, indicating increased debt capital availability [5] - New loan requests in January were up 50% from the prior year, reflecting heightened investor enthusiasm [5] - Nearly half of the company's loans are located in international markets, with approximately 40% in Europe, where strong fundamentals are driving demand [14][15] Company Strategy and Development Direction - The company is focusing on diversifying its investment channels, targeting multifamily and industrial loans, and expanding its net lease strategy [4][6] - The strategy includes selectively exiting owned real estate properties to redeploy capital into core investments, aiming to maximize long-term shareholder value [8][16] - The company has been active in share repurchases, with $140 million since the program's inception, indicating confidence in the stock's value [9][19] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's performance in 2025, highlighting a strong case for additional upside in the stock as it trades below book value [8][9] - The company anticipates continued positive trends in the real estate market, with expectations for further loan resolutions and capital redeployment [19][50] - Management noted that the current liquidity in the market is beneficial for quicker resolutions of impaired loans, contributing to a stabilized real estate market [56] Other Important Information - The company has a strong balance sheet with $1 billion of liquidity and no debt maturities until 2027 [24][25] - The company has been proactive in accessing various capital markets, executing over $5 billion in transactions in the past year [6][68] - The transition of CFO roles was noted, with Marcin Urbaszek stepping into the position, indicating continuity in leadership [10][25] Q&A Session Summary Question: Thoughts on supporting the value of loans in the portfolio - Management is exploring all opportunities to maximize shareholder value and feels confident about the stock's direction [28] Question: Views on the REO portfolio and specific assets - Management sees improved fundamentals and investor demand in key markets like New York, with potential for exiting assets strategically [31][33] Question: Investment in the Blackstone BREDS Fund - The fund will focus on high-quality core-plus real estate in the U.S. and Canada, with no fees for the fund commitment [37] Question: Future portfolio outlook and focus areas - The company intends to diversify its portfolio while maintaining its core lending strategy, with a focus on risk-adjusted returns [40] Question: Multifamily lending opportunities - Management is optimistic about the multifamily sector, citing structural undersupply and strong performance in their portfolio [44] Question: Timeline for resolving loans and redeploying capital - Management expects to exit certain assets over the year, with a focus on redeploying capital at target returns [50] Question: Impaired loan resolutions and market conditions - The resolution of impaired loans was attributed to the strength of the asset management team and improved market liquidity [56]

Financial Data and Key Metrics Changes - For Q4 2025, the company reported a GAAP net loss of -$32 million or -$0.49 per share, with a book value of $13.04 as of December 31 [3] - Distributable earnings were $14 million or -$0.22 per share, and a cash dividend of $0.25 was paid for the quarter [3] Business Line Data and Key Metrics Changes - New originations in Q4 totaled $424 million, surpassing repayments of $380 million, indicating a positive trend in loan origination [8] - Over 75% of new originations were concentrated in multifamily and industrial loans, which are showing resilient fundamentals [5] Market Data and Key Metrics Changes - The company ended the year with over $880 million in liquidity, including $85 million in cash and $700 million in undrawn capacity on the corporate revolver [9] - The weighted average risk rating on the portfolio is 3.2, with a debt-to-equity ratio of 2.2 times and a total leverage ratio of 3.9 times, consistent with target ranges [9] Company Strategy and Development Direction - The company aims to strengthen its liquidity position and has successfully closed a $650 million term loan B, reducing the coupon to SOFR plus 250 basis points [4] - A focus on geographic diversification was highlighted, with the company closing its first loan in Europe, which is part of a strategic effort to build its real estate credit platform [4][5] - The company plans to implement an aggressive resolution strategy for watchlist assets and select office assets to compress the discount of its stock price to book value [6] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the market improving and highlighted the importance of engaging with tenants to optimize asset monetization [7] - The dividend policy is under active evaluation as part of a broader capital allocation discussion, balancing near-term earnings visibility with long-term shareholder value [7] Other Important Information - The company downgraded certain loans to risk rating 5, resulting in total incremental CECL provisions of $44 million during the quarter [8] - The company repurchased over $9 million of common stock at a weighted average share price of $8.24 during the quarter, with a total of $43 million repurchased for the full year [10] Q&A Session Summary Question: Will KREF consider a complete overhaul of its business if the stock does not recover? - Management indicated that they are focused on executing their current business plan and believe that progress on REO will lead to better market recognition [12][13] Question: What does success look like for the company by the end of 2026? - Success is defined as monetizing or liquidating the majority of the watchlist and REO assets, with a focus on clarity in the office portfolio [16][18] Question: Will there be a significant portion of the portfolio under-earning in 2026? - Management noted that while some assets are underperforming, they expect contractual payments to continue and see potential upside from resolving REO assets [25][27] Question: How is the dividend policy being evaluated? - The company is taking a rational financial approach to the dividend, focusing on empirical data rather than market sentiment [28][29] Question: What is the outlook for commercial real estate credit demand? - There is an increasing allocation to real estate credit, with institutional investors shifting focus back to the sector, particularly in opportunistic and value-add areas [48][50] Question: How have recent rate cuts affected interest in REO assets? - Management believes that rate cuts are helping liquidity in the market, although the overall sentiment for real estate is positive due to a lack of sellers [54][55] Question: What makes an office loan attractive today? - The company is focused on lending to newer, high-quality assets with stabilized cash flows and long-term leases, minimizing leasing risk [58][59]

Financial Data and Key Metrics Changes - For Q4 2025, the company reported a GAAP net loss of $32 million or $0.49 per share, with a book value of $13.04 as of December 31 [3] - Distributable earnings were $14 million or $0.22 per share, and a cash dividend of $0.25 was paid for the quarter [3] Business Line Data and Key Metrics Changes - The company experienced $1.5 billion in repayments, consistent with 2024 levels, and $1.1 billion in new originations, with over 75% of new originations concentrated in multifamily and industrial loans [5] - The company is focused on maintaining and selectively growing the portfolio within on-theme asset classes and top-tier MSAs [6] Market Data and Key Metrics Changes - The company ended the year with over $880 million in liquidity, including $85 million in cash and $700 million in undrawn capacity on the corporate revolver [10] - The weighted average risk rating on the portfolio is 3.2, with a debt-to-equity ratio of 2.2 times and a total leverage ratio of 3.9 times [10] Company Strategy and Development Direction - The company aims to execute an aggressive resolution strategy for a significant portion of its watchlist assets and select office assets to compress the discount of its stock price to book value [6] - The company is strategically building its real estate credit platform in Europe, having closed its first loan in the region [4] Management's Comments on Operating Environment and Future Outlook - Management noted that 2026 will be a year of transition, with a focus on repositioning the loan portfolio for improved earnings [6] - The market is improving, and management remains engaged with tenants, particularly regarding the Mountain View asset [7] Other Important Information - The company repurchased over $9 million of common stock at a weighted average share price of $8.24 during the quarter, with a total of $43 million repurchased for the full year [10][11] - The board is actively evaluating the dividend as part of a broader capital allocation discussion [8] Q&A Session Summary Question: Will KREF consider a complete business revamp if the stock does not pull to par? - Management expressed optimism about the portfolio's recognition and emphasized the importance of executing their business plan [13][15] Question: What does success look like by the end of 2026? - Management indicated the goal is to liquidate the vast majority of the watchlist and clarify the office portfolio, with significant progress expected on REO assets [16][18] Question: Will there be a significant portion of the portfolio under-earning in 2026? - Management acknowledged some assets are dragging down earnings but emphasized the potential for near-term opportunities to convert REO assets into performing loans [24][25] Question: How is the company viewing the demand for commercial real estate credit? - Management noted increased allocations to real estate credit and equity, with a shift back into the sector observed among institutional allocators [46][48] Question: Have recent rate cuts increased interest in REO assets? - Management indicated that rate cuts are helping liquidity in the market, with a noted lack of sellers at opportunistic prices [53][54] Question: What makes an office loan attractive today? - Management stated that lending on newer, high-quality assets with stabilized cash flows is where they see attractive opportunities [56][57]

Core Viewpoint - Invesco is an independent investment management firm focused on enhancing the investment experience for individuals [1] Group 1 - Invesco emphasizes the importance of understanding investment objectives, risks, charges, and expenses before making investment decisions [1] - The firm provides educational information but does not offer specific investment recommendations or tax advice [1] - Invesco's opinions are based on current market conditions and may change without notice, indicating a dynamic approach to investment management [1] Group 2 - Invesco Distributors, Inc. serves as the US distributor for Invesco Ltd.'s retail products and collective trust funds [1] - The company operates through various affiliated investment advisers that provide advisory services without selling securities [1] - Invesco Unit Investment Trusts are distributed by Invesco Capital Markets, Inc. and other broker-dealers, highlighting the firm's extensive distribution network [1]

Financial Data and Key Metrics Changes - For Q3 2025, the company reported GAAP net income of $8 million or $0.12 per share, with a book value of $13.78 per share as of September 30, 2025 [3] - The company reported a distributable loss of $2 million, primarily due to taking ownership of the Raleigh Multifamily property, with distributable earnings (DE) of $12 million or $0.18 per share before net realized losses [3][7] - The dividend paid for the third quarter was $0.25 per share, with distributable earnings of negative $0.03 per share [7][8] - Book value per share decreased by 0.4% quarter-over-quarter, remaining mostly unchanged at $13.78 [8] Business Line Data and Key Metrics Changes - The company has been actively lending, expecting over $400 million in originations for Q4 2025, having already closed $110 million across the U.S. and Europe [5] - The company’s portfolio currently stands at $5.9 billion, with repayments of $480 million received in the quarter [9] - Year-to-date, the company has received $1.1 billion in repayments and originated $719 million, with expectations of over $1.5 billion in repayments in 2026 [9][12] Market Data and Key Metrics Changes - The commercial real estate lending market remains robust, with a $1.5 trillion wall of maturities expected over the next 18 months [4] - The debt markets are liquid, with banks returning to the market and increasing back leverage lending [4] - The company has established a dedicated European real estate credit platform, originating over $2.5 billion to date [5][6] Company Strategy and Development Direction - The company is focused on optimizing its REO portfolio and redeploying capital efficiently for growth [14] - The company aims to match repayments with originations, maintaining a disciplined approach to capital deployment [39] - The company is exploring opportunities for consolidation in the industry to enhance liquidity and attract more shareholders [62] Management's Comments on Operating Environment and Future Outlook - Management expressed a positive sentiment towards the real estate market, noting strengthening fundamentals and lagging values [4] - The company is optimistic about the recovery in the life sciences sector, seeing early signs of demand from sponsors [26] - Management indicated that they are continuously evaluating the timing of repayments and originations, expecting to optimize returns to shareholders [39][42] Other Important Information - The company has a total CECL reserve of $160 million, representing around 3% of the loan portfolio, with 85% of the loan portfolio rated 3 or better [12] - The company has no final facility maturities until 2027 and no corporate debt due until 2030, providing a strong liquidity position of $933 million [10][11] Q&A Session Summary Question: Clarification on lower leverage and higher liquidity - Management indicated that the lower leverage and higher liquidity were primarily due to timing issues related to repayments and originations, rather than a defensive positioning [21][22] Question: Impact of repayments on future earnings - Management noted that while there may be a lag in earnings due to the timing of repayments and originations, they do not expect to always be behind and anticipate some quarters will be ahead [24] Question: Update on life science loan portfolio - Management reported a mix of leasing updates and noted that they are seeing early signs of recovery in tenant demand within the life sciences sector [26] Question: NPV analysis on sub-performing deals - Management stated that they continuously evaluate the trade-offs between holding assets for potential appreciation versus selling and redeploying capital [32][33] Question: Timeline for improving ROE - Management provided a timeline for recovering REO, estimating that half of the impacted assets could be stabilized in the near term, with others taking longer [43][44] Question: Comparison of EU loans versus U.S. loans - Management highlighted that while the quality of real estate and sponsorship is similar, the European market is heavily banked, and loan sizes tend to be larger [51][52]

Financial Data and Key Metrics Changes - For Q3 2025, the company reported GAAP net income of $8 million or $0.12 per share, with a book value of $13.78 per share, reflecting a decrease of 0.4% quarter over quarter [3][12] - The company reported a distributable loss of $2 million, primarily due to taking ownership of the Raleigh Multifamily property, with distributable earnings (DE) of negative $0.03 per share, or $0.18 per share excluding losses [3][7] - A cash dividend of $0.25 was paid for the third quarter [3] Business Line Data and Key Metrics Changes - The company has been actively lending, expecting over $400 million in originations for Q4 2025, having already closed $110 million across the U.S. and Europe [5][9] - The company’s portfolio currently stands at $5.9 billion, with repayments of $480 million received in the quarter and $1.1 billion year-to-date [9][12] - The company downgraded the Cambridge Life Science Loan from risk rated 3 to 4, increasing CECL provisions due to this downgrade [8][12] Market Data and Key Metrics Changes - The commercial real estate lending market remains robust, with a $1.5 trillion wall of maturities expected over the next 18 months, and banks returning to the market [4] - The company has established a dedicated European real estate credit platform, originating over $2.5 billion to date, and closed its first European loan in October [5][6] Company Strategy and Development Direction - The company aims to optimize its REO portfolio and redeploy capital efficiently, focusing on stabilizing and selling assets to unlock embedded earnings power of $0.13 per share per quarter [8][14] - The company is committed to maintaining a disciplined approach to lending, targeting institutional sponsors and high-quality real estate [7][12] - The company has built a dedicated asset management platform, K-Star, managing over $37 billion in loans [7] Management's Comments on Operating Environment and Future Outlook - Management expressed a positive sentiment towards the real estate market, noting strengthening fundamentals and lagging values [4] - The company anticipates greater than $1.5 billion in repayments in 2026, expecting to match repayments with originations [9] - Management remains optimistic about the life science sector, noting early signs of recovery in tenant demand [26][32] Other Important Information - The company ended the quarter with near-record liquidity levels of $933 million, including over $200 million in cash [10] - The total CECL reserve at quarter end is $160 million, representing around 3% of the loan portfolio [12] Q&A Session Summary Question: Clarification on lower leverage and higher liquidity - Management indicated that the lower leverage and higher liquidity were primarily due to timing issues related to repayments and originations, rather than a defensive positioning [16][22] Question: Impact of repayments on future earnings - Management noted that while there may be a lag in earnings due to the timing of repayments and originations, they do not expect to always be behind and anticipate some quarters will be ahead [23][24] Question: Update on life science loan portfolio - Management acknowledged seeing early signs of recovery in tenant demand within the life science sector, although most assets are lent to larger pharma companies [25][26] Question: NPV analysis on sub-performing deals - Management stated they continuously evaluate the trade-offs between holding assets for potential appreciation versus selling and redeploying capital [31][33] Question: Current ROE and timeline for improvement - Management provided a timeline for improving ROE, indicating that they expect to recover about half of the impacted assets in the near term, with others taking longer [42][44] Question: Comparison of EU loans versus U.S. loans - Management highlighted that while the quality of real estate and sponsorship is similar, the opportunity set in Europe differs, with larger loan sizes and a more bank-dominated market [50][52]

Financial Data and Key Metrics Changes - The company reported GAAP net income of $8 million or $0.12 per share for Q3 2025, with a book value of $13.78 per share as of September 30, 2025 [3][4] - A distributable loss of $2 million was reported, primarily due to taking ownership of a multifamily property, with distributable earnings before net realized losses at $12 million or $0.18 per share [4][9] - The company paid a cash dividend of $0.25 for the third quarter [4] Business Line Data and Key Metrics Changes - The company expects over $400 million in originations for Q4 2025, having already closed $110 million across the U.S. and Europe [6] - The portfolio managed by KSTAR is over $37 billion in loans, with the company acting as special servicer on $45 billion of CMBS [8] - The company downgraded the risk rating of the Cambridge Life Science loan from risk rated three to four, leading to increased CECL provisions [10] Market Data and Key Metrics Changes - The commercial real estate lending market remains robust, with a $1.5 trillion wall of maturities expected over the next 18 months [5] - The company received repayments of $480 million in Q3 2025, with year-to-date repayments totaling $1.1 billion [10][11] - The company anticipates over $1.5 billion in repayments for 2026, aiming to match repayments with originations [11] Company Strategy and Development Direction - The company is focused on optimizing its REO portfolio and redeploying capital efficiently for growth [17] - The company is strategically building its European real estate credit platform, having originated over $2.5 billion to date [7] - The company aims to maintain a disciplined approach to lending, targeting institutional sponsors and high-quality real estate [7] Management's Comments on Operating Environment and Future Outlook - Management noted a positive sentiment in the real estate market as investors recognize lagging values and strengthening fundamentals [5] - The company is encouraged by the market backdrop and momentum, with a focus on safety and lending on reset values below replacement costs [5][14] - Management expressed optimism about the origination pipeline and the potential for significant opportunities ahead [17] Other Important Information - The company ended the quarter with near-record liquidity levels of $933 million, including over $200 million in cash [13] - The overall financing availability is $7.7 billion, with 77% of financing being non-mark-to-market [13][14] - The company has repurchased $34 million of common stock year-to-date, totaling over $140 million since inception [13] Q&A Session Summary Question: Clarification on lower leverage and higher liquidity - Management indicated that the lower leverage and higher liquidity were primarily due to timing issues related to repayments and originations, rather than a defensive positioning [20][25] Question: Impact of repayment lag on earnings - Management stated that while there may be some lag in earnings due to timing, they do not expect to always be behind in capital deployment [30][32] Question: Update on life science loan portfolio - Management noted early signs of recovery in tenant demand within the life science sector, although most assets are leased to larger pharma companies [34] Question: State of dialogue with life science sponsors - Management confirmed ongoing negotiations with the sponsor of the downgraded Cambridge loan, with no significant discussions on other loans at this time [38][39] Question: NPV analysis on sub-performing deals - Management regularly evaluates the trade-offs between holding and liquidating assets, focusing on maximizing outcomes for quality real estate [41][42] Question: Current ROE and timeline for improvement - Management outlined a timeline for improving ROE, with expectations for near-term recovery from specific assets [56][58] Question: Comparison of EU loans to U.S. loans - Management highlighted similarities in quality and sponsorship between EU and U.S. loans, with some differences in loan sizes and market dynamics [66][68]

Financial Data and Key Metrics Changes - For Q3 2025, the company reported GAAP net income of $8 million or $0.12 per share, with a book value of $13.78 per share, reflecting a decrease of 0.4% quarter over quarter [3][7] - The company reported a distributable loss of $2 million, primarily due to taking ownership of the Raleigh Multifamily property, with distributable earnings (DE) of negative $0.03 per share, or $0.18 per share excluding losses [3][6] - A cash dividend of $0.25 was paid for the third quarter [3] Business Line Data and Key Metrics Changes - The company expects over $400 million in originations for Q4 2025, having already closed $110 million across the U.S. and Europe [5][8] - The company has a current portfolio of $5.9 billion, with repayments of $480 million received in the quarter, totaling $1.1 billion year to date [7][8] - The weighted average risk rating of the current portfolio is 3.1 on a 5-point scale, with 85% of the loan portfolio rated 3 or better [10][11] Market Data and Key Metrics Changes - The commercial real estate lending market remains robust, with a $1.5 trillion wall of maturities expected over the next 18 months [4] - The debt markets are liquid, with banks returning to the market and increasing back leverage lending [4] - The company has strategically built its European real estate credit platform, originating over $2.5 billion to date [5] Company Strategy and Development Direction - The company is focused on optimizing its REO portfolio and redeploying capital efficiently for growth [12] - The company has built a dedicated asset management platform called K-Star, managing over $37 billion in loans [6] - The company aims to match repayments with originations, maintaining a disciplined approach to capital deployment [9][40] Management's Comments on Operating Environment and Future Outlook - Management expressed a positive sentiment towards the real estate market, noting strengthening fundamentals and lagging values [4] - The company anticipates greater than $1.5 billion in repayments in 2026, with a strong origination pipeline [8] - Management is optimistic about the recovery in the life sciences sector, seeing early signs of demand from tenants [26] Other Important Information - The company has no final facility maturities until 2027 and no corporate debt due until 2030, with near-record liquidity levels of $933 million [9][10] - The total CECL reserve at quarter end is $160 million, representing around 3% of the loan portfolio [11] Q&A Session Summary Question: Clarification on lower leverage and higher liquidity - Management indicated that the lower leverage and higher liquidity were primarily due to timing issues related to repayments and originations, rather than a defensive positioning [15][20] Question: Impact of repayments on future earnings - Management stated that while there may be a lag in earnings due to the timing of repayments and originations, they do not expect to be consistently behind in earnings [22][24] Question: Update on life science loan portfolio - Management noted a mix of tenant demand, with some early signs of recovery in the life sciences sector, particularly from larger pharma companies [25][26] Question: State of dialogue with life science sponsors - Management confirmed ongoing negotiations with sponsors, particularly regarding the Cambridge loan downgrade, but no significant discussions outside normal updates [30][31] Question: NPV analysis on sub-performing deals - Management regularly evaluates the trade-offs between holding and selling sub-performing assets, emphasizing the importance of quality real estate and potential future value [32][34] Question: Current ROE and timeline for improvement - Management outlined a timeline for improving ROE, with expectations to recover a significant portion of REO in the near term, particularly from specific assets [44][46] Question: Comparison of EU loans versus U.S. loans - Management highlighted similarities in quality and sponsorship between EU and U.S. loans, but noted differences in market structure and loan sizes [51][53]